These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 15309006)

  • 1. Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction.
    Gibson CM; Murphy SA; Morrow DA; Aroesty JM; Gibbons RJ; Gourlay SG; Barron HV; Giugliano RP; Antman EM; Braunwald E
    Am Heart J; 2004 Aug; 148(2):336-40. PubMed ID: 15309006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiographic perfusion score in patients treated with PCI at late angiography following fibrinolytic administration for ST-segment elevation myocardial infarction is associated with morbidity and mortality at 30 days.
    Pride YB; Buros JL; Lord E; Southard MC; Harrigan CJ; Ciaglo LN; Sabatine MS; Cannon CP; Gibson CM;
    J Thromb Thrombolysis; 2008 Oct; 26(2):106-12. PubMed ID: 17624497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction.
    Gibson CM; Murphy SA; Kirtane AJ; Giugliano RP; Cannon CP; Antman EM; Braunwald E;
    J Am Coll Cardiol; 2004 Sep; 44(5):980-7. PubMed ID: 15337207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of hyperemic epicardial flow to outcomes among patients with ST-segment elevation myocardial infarction receiving fibrinolytic therapy.
    Gibson CM; Pride YB; Buros JL; Kunadian V; Southard MC; Harrigan CJ; Ciaglo LN; Sabatine MS; Cannon CP; Braunwald E
    Am J Cardiol; 2008 May; 101(9):1232-8. PubMed ID: 18435949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI angiographic study.
    Brener SJ; Moliterno DJ; Aylward PE; van't Hof AW; Ruźyllo W; O'Neill WW; Hamm CW; Westerhout CM; Granger CB; Armstrong PW;
    Eur Heart J; 2008 May; 29(9):1127-35. PubMed ID: 18375399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction.
    Karmpaliotis D; Turakhia MP; Kirtane AJ; Murphy SA; Kosmidou I; Morrow DA; Giugliano RP; Cannon CP; Antman EM; Braunwald E; Gibson CM;
    Am J Cardiol; 2004 Nov; 94(9):1113-7. PubMed ID: 15518603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction.
    Gibson CM; Cannon CP; Murphy SA; Marble SJ; Barron HV; Braunwald E;
    Circulation; 2002 Apr; 105(16):1909-13. PubMed ID: 11997276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of a negative residual stenosis following rescue/adjunctive percutaneous coronary intervention with impaired myocardial perfusion and adverse outcomes among ST-segment elevation myocardial infarction patients.
    Gibson CM; Kirtane AJ; Boundy K; Ly H; Karmpaliotis D; Murphy SA; Giugliano RP; Cannon CP; Antman EM; Braunwald E;
    J Am Coll Cardiol; 2005 Feb; 45(3):357-62. PubMed ID: 15680712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
    Gibson CM; Kirtane AJ; Morrow DA; Palabrica TM; Murphy SA; Stone PH; Scirica BM; Jennings LK; Herrmann HC; Cohen DJ; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):756-61. PubMed ID: 16996854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is visual interpretation of coronary epicardial flow reliable in patients with ST-elevation myocardial infarction undergoing primary angioplasty? Insights from the angiographic substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Alhadramy O; Westerhout CM; Brener SJ; Granger CB; Armstrong PW;
    Am Heart J; 2010 May; 159(5):899-904. PubMed ID: 20435202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction.
    Gibson CM; Pride YB; Buros JL; Lord E; Shui A; Murphy SA; Pinto DS; Zimetbaum PJ; Sabatine MS; Cannon CP; Josephson ME;
    J Am Coll Cardiol; 2008 Feb; 51(5):546-51. PubMed ID: 18237683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiographic and clinical outcome after percutaneous coronary interventions following combined fibrinolytic therapy in acute myocardial infarction.
    Dudek D; Dziewierz A; Rakowski T; Siudak Z; Wizimirski M; Legutko J; Batruś S; Mielecki W; Rzeszutko L; Zmudka K; Dubiel JS
    Kardiol Pol; 2006 Mar; 64(3):239-47; discussion 248-9. PubMed ID: 16583321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study.
    Ali A; Cox D; Dib N; Brodie B; Berman D; Gupta N; Browne K; Iwaoka R; Azrin M; Stapleton D; Setum C; Popma J;
    J Am Coll Cardiol; 2006 Jul; 48(2):244-52. PubMed ID: 16843170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of reperfusion regimens with or without tirofiban in ST-elevation acute myocardial infarction.
    Martínez-Ríos MA; Rosas M; González H; Peña-Duque MA; Martínez-Sánchez C; Gaspar J; García H; Gaxiola E; Delgado L; Carrillo J; Leyva JL; Lupi E;
    Am J Cardiol; 2004 Feb; 93(3):280-7. PubMed ID: 14759375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of corrected thrombolysis in myocardial infarction frame count and ST-segment resolution to myocardial tissue perfusion after acute myocardial infarction.
    Li CM; Zhang XH; Ma XJ; Zhu XL
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):312-7. PubMed ID: 18288744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.
    Brener SJ; Westerhout CM; Fu Y; Todaro TG; Moliterno DJ; Wagner GS; Granger CB; Armstrong PW;
    Am Heart J; 2009 Nov; 158(5):755-60. PubMed ID: 19853693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Angiographic Perfusion Score in Reperfusion Success and Risk Stratification Following Percutaneous Coronary Intervention in Acute Coronary Syndromes without Thrombolytic Pre-treatment.
    Karn AL; Ahsan SA; Chowdhury S; Hasan MN
    Mymensingh Med J; 2021 Jan; 30(1):202-207. PubMed ID: 33397875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and applicability of computer-assisted myocardial blush quantification after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Haeck JD; Gu YL; Vogelzang M; Bilodeau L; Krucoff MW; Tijssen JG; De Winter RJ; Zijlstra F; Koch KT
    Catheter Cardiovasc Interv; 2010 Apr; 75(5):701-6. PubMed ID: 20091824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
    Bolognese L; Falsini G; Schwenke C; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
    Am J Cardiol; 2012 Jan; 109(1):67-74. PubMed ID: 21943940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of creatine kinase-myocardial band release to Thrombolysis in Myocardial Infarction perfusion grade after intracoronary stent placement: an ESPRIT substudy.
    Gibson CM; Murphy SA; Marble SJ; Cohen DJ; Cohen EA; Lui HK; Young J; Kitt MM; Lorenz TJ; Tcheng JE
    Am Heart J; 2002 Jan; 143(1):106-10. PubMed ID: 11773919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.